Total planned funding: $38,873,110
Clear active filters
U.S. Department of State
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| South Africa | $9,762,028 |
| Mozambique | $5,573,250 |
| Botswana | $2,916,775 |
| Malawi | $2,590,472 |
| Tanzania | $2,348,500 |
| Zambia | $2,147,280 |
| Kenya | $2,045,971 |
| Ukraine | $2,000,000 |
| Ethiopia | $1,686,788 |
| Uganda | $1,668,979 |
| Caribbean Region | $1,000,000 |
| Eswatini | $911,365 |
| Nigeria | $614,250 |
| Democratic Republic of the Congo | $568,000 |
| Ghana | $537,000 |
| Zimbabwe | $505,000 |
| Lesotho | $382,285 |
| Côte d'Ivoire | $379,018 |
| Haiti | $373,943 |
| Rwanda | $212,136 |
| Cameroon | $170,000 |
| Namibia | $140,000 |
| Guyana | $136,286 |
| Central America Region | $98,784 |
| Vietnam | $65,000 |
| Angola | $40,000 |
Organizational Types
| Own Agency | $20,821,598 |
| Other USG Agency | $17,971,512 |
| Implementing Agency | $80,000 |
Program Areas
| Management and Operations | $14,549,984 |
| Governance and Systems | $9,891,323 |
| Care | $9,395,510 |
| Prevention | $3,554,636 |
| Treatment | $1,286,147 |
| Testing | $195,510 |
Budget Codes
| HVMS: Management and Operations | $14,549,984 |
| HKID: Care: Orphans and Vulnerable Children | $6,288,875 |
| OHSS: Health Systems Strengthening | $5,942,052 |
| HLAB: Laboratory Infrastructure | $3,230,147 |
| HBHC: Care: Adult Care and Support | $2,480,959 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $1,433,214 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $996,709 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $906,598 |
| HTXS: Treatment: Adult Treatment | $877,768 |
| HVSI: Strategic Information | $719,124 |
| HVTB: Care: TB/HIV | $423,986 |
| PDTX: Treatment: Pediatric Treatment | $249,801 |
| PDCS: Care: Pediatric Care and Support | $201,690 |
| HVCT: Testing: HIV Testing and Counseling | $195,510 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $180,201 |
| HTXD: Treatment: ARV Drugs | $158,578 |
| HMBL: Biomedical Prevention: Blood Safety | $14,720 |
| HMIN: Biomedical Prevention: Injection Safety | $14,385 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,809 |